Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabotegravir Monotherapy in HIV-1
NCT00920426Phase 2Completed
- Sponsor
- ViiV Healthcare
- Start
- Jun 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabotegravir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Jun 2009; status: completed.
02
Drugs
cabotegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00920426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00920426.